Shandong Wohua Pharmaceutical Co., Ltd. (SHE:002107)
China · Delayed Price · Currency is CNY 6.95
-0.41 (-5.57%)
Sep 10, 2026, 2:10 PM CST
SHE:002107 Revenue
Shandong Wohua Pharmaceutical had revenue of 174.30M CNY in the quarter ending June 30, 2026, a decrease of -16.01%. This brings the company's revenue in the last twelve months to 784.94M, down -1.14% year-over-year. In the year 2025, Shandong Wohua Pharmaceutical had annual revenue of 816.95M with 6.96% growth.
Revenue (ttm)
784.94M
Revenue Growth
-1.14%
P/S Ratio
5.41
Revenue / Employee
771.06K
Employees
1,018
Market Cap
4.25B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 816.95M | 53.16M | 6.96% |
| Dec 31, 2024 | 763.79M | -145.71M | -16.02% |
| Dec 31, 2023 | 909.51M | -105.31M | -10.38% |
| Jan 1, 2023 | 1.01B | 72.14M | 7.65% |
| Jan 1, 2022 | 942.67M | -63.41M | -6.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shenzhen Neptunus Bioengineering | 23.66B |
| Jinling Pharmaceutical Company | 3.18B |
| Jinhe Biotechnology CO., LTD. | 2.94B |
| Zhejiang Starry Pharmaceutical | 2.46B |
| Tibet Weixinkang Medicine | 1.13B |
| Harbin Medisan Pharmaceutical | 805.09M |
| Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD | 737.90M |
| Newland Pharmaceutical | 710.55M |